CompaniesObsidian Therapeutics
Obsidian Therapeutics logo

Obsidian Therapeutics

active
Cambridge, MA, United States
Founded 2017
Website
About

Cell & Gene Therapies

Areas of Focus

Categories

Gene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapyBoston & New England
Team (20)
Cariad Chester
Cariad Chester
Obsidian Therapeutics
team_member
Cassian Yee
Obsidian Therapeutics
team_member
Chris Klebanoff
Obsidian Therapeutics
team_member
Dana Alexander
Dana Alexander
Obsidian Therapeutics
team_member
Heidi Hagen
Heidi Hagen
Obsidian Therapeutics
team_member
Jeffrey Trigilio
Jeffrey Trigilio
Obsidian Therapeutics
team_member
View all 20 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

52

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT06060613
Hover over trial bars to see details

Recent Trials

NCT06060613Lead Sponsor
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
52 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2028
Funding History (1)
D
Dec 8, 2017
Filing
Locations (1)
Headquarters
Cambridge, MA, United States
Map

Loading map...